[1] |
Loeser RF. Aging processes and the development of osteoarthritis[J]. Curr Opin Rheumatol, 2013, 25(1):108-113.
|
[2] |
邵虹,张景霞,赵长红,等.老年军人生活质量与慢性病关系的研究[J].中国老年学杂志,2005,25(12):1460-1461.
|
[3] |
中华医学会风湿病学分会.骨关节炎诊断及治疗指南[J].中华风湿病学杂志,2010,14(6):416-419.
|
[4] |
Cameron KL, Hsiao MS, Owens BD, et al. Incidence of physician-diagnosed osteoarthritis among active duty United States military service members[J]. Arthritis Rheum, 2011, 63(10):2974-2982.
|
[5] |
Kim I, Kim HA, Seo YI, et al. The prevalence of knee osteoarthritis in elderly community residents in Korea[J]. J Korean Med Sci, 2010, 25(2):293-298.
|
[6] |
Sudo A, Miyamoto N, Horikawa K, et al. Prevalence and risk factors for knee osteoarthritis in elderly Japanese men and women[J]. J Orthop Sci, 2008,13(5):413-418.
|
[7] |
田少奇,王斌,孙康,等.青岛地区中老年人膝骨关节炎流行病学研究[J/CD].中华关节外科杂志(电子版),2015,9(6):762-766.
|
[8] |
张豪杰,郭涛.贵阳市症状性膝骨关节炎发病相关因素调查及分析[J].贵阳中医学院学报,2015,37(1):47-50.
|
[9] |
Kopec JA, Rahman MM, Berthelot JM, et al. Descriptive epidemiology of osteoarthritis in British Columbia, Canada[J]. J Rheumatol, 2007,34(2):386-393.
|
[10] |
Kopec JA, Rahman MM, Sayre EC, et al. Trends in physician-diagnosed osteoarthritis incidence in an administrative database in British Columbia, Canada, 1996-1997 through 2003-2004[S]. 2008, 59(7):929-934.
|
[11] |
Showery JE, Kusnezov NA, Dunn JC, et al. The Rising Incidence of Degenerative and Posttraumatic Osteoarthritis of the Knee in the United States Military[J]. J Arthroplasty, 2016,31(10):2108-2114.
|
[12] |
李宁华.中老年人群骨关节炎的流行病学特征[J].中国临床康复,2005,9(38):133-135.
|
[13] |
王宇强,王小华,刘天盛,等.西安、天津、广州3城市膝骨性关节炎患者、门诊就治者及社区人员膝骨关节炎主要致病因素:多中心整群抽样分层调查[J]. 中国组织工程研究与临床康复,2009,13(41):8155-8159.
|
[14] |
刘鹏,观美华,高利霞,等.中老年人骨关节炎流行病学研究[J].吉林医学,2012,33(12):2576-2576.
|
[15] |
Schett G, Kleyer A, Perricone C, et al. Diabetes is an Independent predictor for severe osteoarthritis: results from a longitudinal cohort study[J]. Diabetes Care, 2013, 36(2):403-409.
|
[16] |
Onur T, Wu R, Metz L, et al. Characterisation of osteoarthritis in a small animal model of type 2 diabetes mellitus[J]. Bone Joint Res, 2014, 3(6):203-211.
|
[17] |
Eymard F, Parsons C, Edwards MH, et al. Diabetes is a risk factor for knee osteoarthritis progression[J]. Osteoarthritis Cartilage, 2015, 23(6):851-859.
|
[18] |
Laiguillon MC, Courties A, Houard X, et al. Characterization of diabetic osteoarthritic cartilage and role of high glucose environment on chondrocyte activation: toward pathophysiological delineation of diabetes mellitus-related osteoarthritis[J]. Osteoarthritis Cartilage, 2015, 23(9):1513-1522.
|
[19] |
Yang Q, Chen C, Wu S, et al. Advanced glycation end products downregulates peroxisome proliferator-activated receptor gamma expression in cultured rabbit chondrocyte through MAPK pathway[J]. Eur J Pharmacol, 2010, 649(1-3):108-114.
|
[20] |
陈铖,马翅,张莹,等.AGEs对兔软骨细胞TNF-α和MMP-13表达的影响及其机制研究[J].湖南师范大学学报(医学版),2013,10(04):23-28.
|
[21] |
Chen C, Ma C, Zhang Y, et al. Pioglitazone inhibits advanced glycation end product-induced TNF-α and MMP-13 expression via the antagonism of NF-κB activation in chondrocytes[J]. Pharmacology, 2014, 94(5-6):265-272.
|
[22] |
Li Y, Zhang Y, Chen C, et al. Establishment of a rabbit model to study the influence of advanced glycation end products accumulation on osteoarthritis and the protective effect of pioglitazone[J]. Osteoarthritis Cartilage, 2016, 24(2):307-314.
|
[23] |
Ma C, Zhang Y, Li YQ, et al. The role of PPARy in advanced glycation end products-induced inflammatory response in human chondrocytes[J]. PLoS One, 2015, 10(5):e0125776.
|